YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Obstetrics and Gynecology (산부인과학교실)

1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2024Unique immune characteristics and differential anti-PD-1-mediated reinvigoration potential of CD8 + TILs based on BRCA1/2 mutation status in epithelial ovarian cancers JOURNAL FOR IMMUNOTHERAPY OF CANCER
2024Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical CancerNEW ENGLAND JOURNAL OF MEDICINE
2024Effects of subcutaneous drain on wound dehiscence and infection in gynecological midline laparotomy: Secondary analysis of a Korean Gynecologic Oncology Group study (KGOG 4001)EJSO
2024Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial JOURNAL OF CLINICAL ONCOLOGY
2024Efficacy of immune-checkpoint inhibitors combined with cytotoxic chemotherapy in advanced or recurrent endometrial cancer: A systematic review and meta-analysisGYNECOLOGIC ONCOLOGY
2024Ticagrelor, but Not Clopidogrel, Attenuates Hepatic Steatosis in a Model of Metabolic Dysfunction-Associated Steatotic Liver Disease NUTRIENTS
2024Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trialLANCET
2024Clinical practice guidelines for cervical cancer: the Korean Society of Gynecologic Oncology guidelines JOURNAL OF GYNECOLOGIC ONCOLOGY
2024Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trialGYNECOLOGIC ONCOLOGY
2024Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines JOURNAL OF GYNECOLOGIC ONCOLOGY
2024Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study CLINICAL CANCER RESEARCH
2024Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial JOURNAL OF CLINICAL ONCOLOGY
2024Prenatal Diagnosis and Clinical Outcomes of Isolated Mega Cisterna MagnaJOURNAL OF CHILD NEUROLOGY
2024Decision-making process for risk-reducing salpingo-oophorectomy among Korean women with hereditary breast cancer: A grounded theory studyEUROPEAN JOURNAL OF ONCOLOGY NURSING
2024Factors affecting the technical outcome of catheter-directed sclerotherapy for ovarian endometriomasEUROPEAN JOURNAL OF RADIOLOGY
2024Efficacy of large language models and their potential in Obstetrics and Gynecology education Obstetrics & Gynecology Science
2024Maternal and Neonatal Outcomes Based on Changes in Glycosylated Hemoglobin Levels During First and Second Trimesters of Pregnancy in Women with Pregestational Diabetes: Multicenter, Retrospective Cohort Study in South Korea Life
2024Oral hormone replacement therapy and uterine volume in Korean adolescents with Turner syndrome: A retrospective case-control studyJOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY
2024Development and validation of artificial intelligence-based analysis software to support screening system of cervical intraepithelial neoplasiaSCIENTIFIC REPORTS
2024RAD51 as an immunohistochemistry-based marker of poly(ADP-ribose) polymerase inhibitor resistance in ovarian cancer FRONTIERS IN ONCOLOGY
1234567891011 90

Recent Submissions

  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links